Mini-symposium: pancreatic pathologyAcinar cell carcinoma of the pancreas and related neoplasms: a review
Section snippets
General features
Despite the fact that the majority of the normal pancreas is composed of acinar cells, acinar cell carcinomas (ACCs) are extremely uncommon and represent only 2% of all pancreatic neoplasms. They can occur at any age but are much more common in adults (mean age = 58 years), and paediatric cases comprise only 6% of all ACCs. Males are affected more frequently (M:F = 3.6:1).1, 2
Clinical presentation
Most patients have non-specific symptoms including abdominal pain, bloating, nausea, vomiting, diarrhoea and weight loss. Since ACCs usually do not obstruct the common bile duct, jaundice is not common. Ten to 15% of the patients, almost invariably those with liver metastases, develop the lipase hypersecretion syndrome, a manifestation of excessive lipase secreted by the tumour into the serum.3 The syndrome is characterized by diffuse subcutaneous fat necrosis and polyarthralgia with or without
Gross features
ACCs may arise in any portion of the pancreas. Most are large, with a mean size of 11 cm, and they are generally more circumscribed than ductal adenocarcinomas. They are usually tan to red, soft and fleshy (Figure 1). Areas of haemorrhage, necrosis and cystic degeneration can be present. A few cases have a diffuse multicystic gross appearance; these acinar cell cystadenocarcinomas are discussed below. Rare ACCs involve the ductal system and, in addition to the solid areas, reveal intraductal
Microscopic features
At low magnification, ACCs are markedly cellular and are devoid of the intervening desmoplastic stroma characteristic of ductal adenocarcinomas (Figure 2). The periphery of the carcinoma may appear circumscribed, often surrounded by a thin fibrous capsule, although capsular invasion and extension into adjacent parenchyma is common. In most cases, necrosis is not prominent. Occasional tumours, however, have abundant coagulative necrosis.
Of the several different architectural patterns described,
Histochemistry
PAS staining after diastase digestion reveals small PAS-positive granules (Figure 7) corresponding to zymogen granules, particularly in the apical aspect of the cells.9 However, the amount varies greatly from case to case and even within different areas of the same tumour. If present, intraluminal secretory concretions and crystals are also PAS-positive.6 Unlike in ductal adenocarcinomas, no intracellular mucin is detected by mucicarmine or alcian blue stains, although occasional focal staining
Immunohistochemistry
The diagnosis depends on the demonstration of acinar differentiation, obtained using antibodies recognizing various pancreatic enzymes that, although specific, show different sensitivity for the diagnosis. Both trypsin (Figure 8) and chymotrypsin are detectable in over 95% of cases and are most diagnostically useful markers; however, some studies have shown less sensitivity for chymotrypsin. Lipase is less commonly identified, in approximately 70–85% of cases. Other markers that are reportedly
Electron microscopy
Zymogen granules are the ultrastructural hallmark of acinar differentiation and occur as electron-dense granules that may vary in number, shape, size and distribution. Typical granules are round, range from 125 to 1000 nm in size and are usually concentrated in the apical cytoplasm, adjacent to the luminal border. A second population of granules has bizarre shapes with a fibrillary internal structure, ranging up to 3500 nm in size. Some of these appear to be membrane bound, but others are free
Molecular findings
By molecular genetic analysis, ACCs very rarely if ever show KRAS, TP53, SMAD4 (DPC4), or CDKN2A(p16) gene mutations, in contrast to pancreatic ductal adenocarcinomas. As a result, immunohistochemically, only rare cases exhibit abnormal nuclear accumulation of the p53 protein, and DPC4 is retained. However, a high frequency of allelic loss on chromosomes 11p, 4q and 16q has been identified. In addition, 25% of ACCs have mutations in APC/β-catenin pathway, either activating mutations of the
Acinar cell cystadenocarcinoma
A cystic variant of ACC is well documented but is extremely uncommon; only a handful of cases have been reported.15, 16, 17, 18, 19 Grossly, the lesions are large (mean, 24 cm), circumscribed and diffusely cystic with individual locules ranging from a few millimetres to several centimetres. Microscopically, the cysts are separated by delicate fibrous septa and lined by single or several layers of neoplastic acinar cells, sometimes forming minute lumina within the epithelial lining (Figure 10).
Mixed acinar carcinomas
Mixed acinar carcinomas exhibit more than one line of differentiation (acinar and neuroendocrine; acinar and ductal; or acinar, neuroendocrine, and ductal), usually with the acinar component predominating. By arbitrary definition, each component must comprise at least 25% of neoplasm for a diagnosis of mixed acinar carcinoma. Although some mixed carcinomas have distinctive histologic features suggesting that more than one line of differentiation exists, in many cases, mixed differentiation is
Differential diagnosis
The main differential diagnosis of ACC is with other pancreatic neoplasms that are characterized by a solid, cellular pattern, namely pancreatic neuroendocrine tumours, pancreatoblastoma, solid–pseudopapillary neoplasm and intraductal tubulopapillary neoplasm (Table 1).
Staging
Pure and mixed ACCs are staged using the TNM staging system for carcinomas of the exocrine pancreas, based on the size and extent of the primary neoplasm, and the presence of regional lymph node and distant metastases.30
Prognosis
The clinical course of ACC is aggressive, although it is usually not as dismal as that of stage-matched ductal adenocarcinomas. The five-year survival rate ranges from 6%1 (based on cases recruited before 1999) to 50%31, 32, 33 in different studies. Patients who present with localized disease have much better prognosis than those who present with metastases, which are most often found in regional lymph nodes and the liver3 although occasionally in lung, cervical lymph nodes and ovary.34 Longer
Research directions
At the molecular level, ACC is very different from other types of pancreatic neoplasms, ductal adenocarcinoma in particular. These observations along with anecdotal demonstration of significant responses to treatment1 suggest there may be promise to identify therapeutic targets for this variant of pancreatic cancer. Because ACCs harbour abnormalities in the APC/β-catenin pathway, chemotherapy directed more towards intestinal-type carcinomas has been tested with some success. Future research
References (35)
- et al.
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma
Hum Pathol
(2000) - et al.
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway
Am J Pathol
(2002) - et al.
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma
Pancreatology
(2009) - et al.
Acinar cell cystadenocarcinoma of the pancreas: report of rare case and review of the literature
Hum Pathol
(2004) - et al.
Pancreatic acinar cell carcinoma: a multi-institutional study
J Gastrointest Surg
(2009) - et al.
Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma
J Gastrointest Surg
(2008) - et al.
672 Patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma
Surgery
(2008) - et al.
Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases
Am J Surg Pathol
(1992) - et al.
Acinar cell neoplasms of the pancreas
- et al.
Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors
J Clin Oncol
(2002)
Tumors of the pancreas
Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms
Am J Surg Pathol
Pancreatic ducts as an important route of tumor extension for acinar cell carcinoma of the pancreas
Am J Surg Pathol
Comparative cytologic features of pancreatic acinar cell carcinoma and islet cell tumor
Diagn Cytopathol
Mixed acinar–endocrine carcinomas of the pancreas
Am J Surg Pathol
The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia
Virchows Arch
Pancreatic secretory enzymes
Cited by (5)
Pancreas
2015, Sternberg's Diagnostic Surgical Pathology: Sixth EditionPoorly differentiated neuroendocrine carcinomas of the pancreas: A clinicopathologic analysis of 44 cases
2014, American Journal of Surgical PathologyTwo rare cases of a solid pseudopapillary neoplasm of the pancreas
2013, Oncology Letters